Suppr超能文献

2022年12月新型冠状病毒肺炎住院治疗对中国四川省医院工作人员的影响。

Impact of COVID-19 hospitalization on December 2022 hospital staff in Sichuan, China.

作者信息

Pu Jing, Fan Mi, Lin Binwei, Du Xiaobo

机构信息

Department of Nursing, Mianyang Central Hospital, Mianyang, China.

Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nan Chong, China.

出版信息

Medicine (Baltimore). 2025 Aug 8;104(32):e43784. doi: 10.1097/MD.0000000000043784.

Abstract

It is unclear how hospital staff infected with coronavirus disease (COVID-19) are diagnosed and treated, and the impact of COVID-19 on hospitals. This study investigated the symptoms, diagnosis, treatment, and impact of the COVID-19 pandemic on hospital workers in December 2022. Overall, 1464 hospital workers were surveyed by an anonymous investigator using the Questionnaire Star APP, File S1, Supplemental Digital Content, https://links.lww.com/MD/P619 (15 items). Among participants, 87.64% were diagnosed with COVID-19 and 78.79% had been infected within 15 days. Higher non-infection rate occurred in males (16.15%), aged >50 years (31.77%), and service workers (32.02%). Of the 1283 infected patients, 14.50%, 40.45%, and 45.05% were diagnosed by nucleic acid detection, antigen testing, and self-diagnosis based on symptoms, respectively. Predominant symptoms included cough (88.54%), fever (79.42%), body pains (73.03%), and expectoration (70.30%). Individuals experiencing symptoms lasting <5 days, 6 to 10 days, 11 to 15 days, and >15 days were 22.53%, 31.33%, 21.67%, and 24.47%, respectively. The 3 most severe symptoms were cough (28.37%), body aches (22.37%), and fever (13.79), with 55.88% participants having severe symptoms lasting <5 days. Critically, 73.3% of infected staff required sick leave (mean 3.2 days), causing severe workforce shortages. Despite mild disease severity (low hospitalization), few underwent lab tests (10.5%), or computer tomography scans (8.2%); 92.52% infected patients received medications to alleviate symptoms, and the most common drugs included antipyretic and analgesic drugs (86.05%), antitussive drugs (56.97%), antiviral drugs (40.61%), and traditional Chinese medicine (33.01%). In summary, COVID-19 spread rapidly across hospitals in December 2022, resulting in high rate of absenteeism, demonstrating that even clinically mild outbreaks can critically disrupt healthcare capacity through staff depletion.

摘要

目前尚不清楚感染冠状病毒病(COVID-19)的医院工作人员是如何被诊断和治疗的,以及COVID-19对医院的影响。本研究调查了2022年12月COVID-19大流行对医院工作人员的症状、诊断、治疗及影响。总体而言,一名匿名调查员使用问卷星APP(文件S1,补充数字内容,https://links.lww.com/MD/P619,共15项)对1464名医院工作人员进行了调查。在参与者中,87.64%被诊断为感染了COVID-19,78.79%在15天内被感染。男性(16.15%)、年龄>50岁者(31.77%)和服务人员(32.02%)的未感染率较高。在1283名感染患者中,分别有14.50%、40.45%和45.05%通过核酸检测、抗原检测和基于症状的自我诊断确诊。主要症状包括咳嗽(88.54%)、发热(79.42%)、身体疼痛(73.03%)和咳痰(70.30%)。症状持续<5天、6至10天、11至15天和>15天的个体分别为22.53%、31.33%、21.67%和24.47%。最严重的3种症状是咳嗽(28.37%)、身体疼痛(22.37%)和发热(13.79%),55.88%的参与者严重症状持续<5天。关键的是,73.3%的感染工作人员需要病假(平均3.

相似文献

1
Impact of COVID-19 hospitalization on December 2022 hospital staff in Sichuan, China.
Medicine (Baltimore). 2025 Aug 8;104(32):e43784. doi: 10.1097/MD.0000000000043784.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
5
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
6
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.

本文引用的文献

2
Diagnosis of Respiratory Sarcopenia for Stratifying Postoperative Risk in Non-Small Cell Lung Cancer.
JAMA Surg. 2025 Jan 1;160(1):66-73. doi: 10.1001/jamasurg.2024.4800.
4
Covid-19 variants: Impact on transmissibility and virulence.
Malays J Pathol. 2022 Dec;44(3):387-396.
6
Household transmission of the SARS-CoV-2 Omicron variant in Denmark.
Nat Commun. 2022 Sep 23;13(1):5573. doi: 10.1038/s41467-022-33328-3.
7
A comparative overview of SARS-CoV-2 and its variants of concern.
Infez Med. 2022 Sep 1;30(3):328-343. doi: 10.53854/liim-3003-2. eCollection 2022.
8
Accurate Interpretation of SARS-CoV-2 Antigen Detection by Immunochromatography.
Front Med (Lausanne). 2022 Jun 29;9:949554. doi: 10.3389/fmed.2022.949554. eCollection 2022.
9
Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic.
Ann Med Surg (Lond). 2022 Jun;78:103797. doi: 10.1016/j.amsu.2022.103797. Epub 2022 May 26.
10
Impact of the COVID-19 pandemic on the mental health of hospital staff: An umbrella review of 44 meta-analyses.
Int J Nurs Stud. 2022 Jul;131:104272. doi: 10.1016/j.ijnurstu.2022.104272. Epub 2022 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验